Jones JK, Tilson HH, Lewis J D. Pharmacoepidemiology: defining the field and its core content. Pharmacoepidemiol Drug Safe. 2012. doi: 10.1002/pds.3198.

Jones JK. Chapter 33. Assessing Causality of Case Reports of Suspected Adverse Events, In: Strom BL, editor. Pharmacoepidemiology. Fifth Edition ed. Chichester: J. Wiley & Sons; 2012. p. 583-600.

Huang HY, Andrews E, Jones JK, Skovron ML, Tilson H. Pitfalls in meta-analyses on adverse events reported from clinical trials. Pharmacoepidemiol Drug Safe. 2011;20:1014-1020.

Brown JJ, Salinas GD, Cohen M, Jones JK, Olson BL, Vaida A, Bates DW. Improving Safe Use of Medication through Internet Education for Healthcare Providers: A Case-Controlled Study. CE Meas. 2011;5:6-12.

Manack A, Motsko SP, Haag-Molkenteller C, Dmochowski R, Goehring Jr., EL, Nguyen-Khoa B, and Jones JK. Epidemiology and Healthcare Utilization of Neurogenic Bladder Patients in a US Claims Database. Neurourol Urodynam. 2011;30:395-401.

Oeffinger KC, Hudson MM, Mertens AC, Smith SM, Mitby PA, Eshelman-Kent DA, Ford JS, Jones JK, Kamani S, Robison LL. Increasing Rates of Breast Cancer and Cardiac Surveillance Among High-Risk Survivors of Childhood Hodgkin Lymphoma Following a Mailed, One-Page Survivorship Care Plan. Pediatr Blood Cancer. 2011 May;56(5):818-24.

Roberts SS, Miller RK, Jones JK, Lindsay KL, Greene MF, Maddrey WC, Williams IT, Liu J, Spiegel RJ. The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009. Birth Defects Res A Clin Mol Teratol. 2010;88:551-559.

Li J, Motsko SP, Goehring EL Jr, Tave A, Pezzullo JC, Jones JK. Prevalence of Pediatric Dyslipidemia: Comparison of a Population-Based Claims Database to National Surveys. Pharmacoepidemiol Drug Safe. 2010;19:1031-1040.

Jones JK, Kamani S, Bush PJ, Hennessey KA, Marfatia A, Shad AT. Development and evaluation of an educational interactive CD-ROM for teens with cancer. Pediatr Blood Cancer. 2010;55:512-519.

Li J, Motsko SP, Goehring EL Jr, Vendiola RM, Maneno M, Jones JK. Longitudinal study on pediatric dyslipidemia in population-based claims database. Pharmacoepidemiol Drug Safe. 2010;19:90-98.

Motsko SP, Russmann S, Ming EE, Singh VP, Vendiola RM, Jones JK. Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events - a cohort study in 359 039 patients from clinical practice. Pharmacoepidemiol Drug Safe. 2009;18:1214-1222.

Pozniak A, Muller L, Salgo M, Jones JK, Larson P, Tweats D. Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept(R), Roche): overview. AIDS Res Ther. 2009;6:18.

Russmann S, Lamerato L, Motsko SP, Pezzullo JC, Farber MD, Jones JK. Risk of Further Decline of Oral Sodium Phosphate or Polyethylene Glycol in Patients with Preexisting Glomerular Filtration Rate Below 60 ml/min. Am J Gastroenterol 2008;103:2707-2716.

Nguyen-Khoa BA, Goehring EL Jr., Werther W, Gower E, Do D, Jones JK. Hospitalized cardiovascular diseases in neovascular age-related macular degeneration. Arch Ophthalmol 2008;126(9):1280-1286.

Motsko SP, Jones JK. Is There an Association between Hypothyroidism and Open-angle Glaucoma in an Elderly Population? An Epidemiologic Study. Ophthalmol 2008;115(9):1581-1584.

Guo JJ, Goehring EL Jr, Jones JK. Chapter 29. The Story of Cisapride and Its Withdrawal from the Market: A Case Study. In: Hartzema AG, Tilson HH & Chan KA, eds. Pharmacoepidemiology and Therapeutic Risk Management, 1st edition. Cincinnati, OH: Harvey Whitney Books; 2008:727-738.

Russmann S, Lamerato L, Marfatia A, Motsko SP, Pezzullo JC, Olds G, Jones JK. Risk of impaired renal function after colonoscopy: A cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol 2007;102:2655-2663.

du Parc E, Nguyen-Khoa BA, Jones JK. Specialized pharmacy education in France. Am J Health-Syst Pharm 2007; 64:1647-50.

Nguyen BA, Goehring EL Jr, Vendiola RM, Pezzullo JC, Jones JK. Epidemiologic study of smell disturbance in two medical insurance claims populations. Arch Otolaryngol Head Neck Surg 2007;133(8):748-757.

Jones JK. The Institute of Medicine's Report on Drug Safety: Constructive and ambitious, but does it go far enough? Clin Pharmacol Ther 2007;81:156-158.

Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez AM, Freedman SB, Goldsmith DI, Huang K, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, Van Puijenbroek E, Williams, Wise RP. Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Safe 2007;16:581-587.

Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez AM, Freedman SB, Goldsmith DI, Huang K, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, Van Puijenbroek E, Williams, Wise RP. Guidelines for submitting adverse event reports for publication. Drug Safety 2007;30:367-373.

Curkendall SM, Lanes S, de Luise C, Stang MR, Jones JK, She D, Goehring Jr EL. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur J Epidemiol 2006;21:803-813.

Curkendall SM, de Luise C, Jones JK, Lanes S, Stang MR, Goehring E, She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan, Canada. Ann Epidemiol 2006;16:63-70.

Jones JK. Chapter 17. Determining Causation from Case Reports. In: Strom BL & Kimmel SE, eds. The Textbook of Pharmacoepidemiology. New York, NY: John Wiley & Sons, Ltd; 2006:277-286.

Spivey RN, Jones JK, Wardell W, Vodra W. Chapter 21. The US FDA in the drug development, evaluation and approval process. In: Griffin JP & O’ Grady J, eds. The Textbook of Pharmaceutical Medicine, 5th edition. Oxford, England: Blackwell Publishing; 2006:602-613.

Wardell W, Vodra W, Jones JK, Spivey RN. Chapter 22. Past evolution and future prospects of the Pharma industry and its regulation in the USA. In: Griffin JP & O’ Grady J, eds. The Textbook of Pharmaceutical Medicine, 5th edition. Oxford, England: Blackwell Publishing; 2006:614-636.

Van Ganse E, Jones JK, Moore N, Le Parc JM, Wall R, Schneid H. A large simple clinical trial prototype for assessment of OTC drug effects using patient-reported data. Pharmacoepidemiol Drug Safe 2005;14:249-255.

Strauss A, Gould AL, Nelsen LM, Wiholm BE, Jones JK. Public-released version of the Adverse Event Reporting System (AERS) database. Clin Ther 2005;27:355-357.

Curkendall SM, Mo J, Glasser DB, Stang MR, Jones JK. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry 2004;65:715-720.

Jones, JK. Spontaneous reports cannot serve as a basis for comparison of two drugs. Am J Cardiol 2003;92:1141-1142.

Guo JJ, Curkendall S, Jones JK, Fife D, Goehring E, She D. Impact of cisapride label changes on codispensing of contraindicated medications. Pharmacoepidemiol Drug Safe 2003;12:295-301.

Dragone MA, Bush PJ, Jones JK, Bearison DJ, Kamani SA. Development and evaluation of an interactive CD-ROM for children with leukemia and their families. Patient Educ Couns 2002;46:299-311.

Jones JK, Fife D, Curkendall SM, Goehring E, Guo JJ, Shannon M. Coprescribing and codispensing of cisapride and contraindicated drugs. JAMA 2001;286:1607-1609.

Jones JK. Pharmacogenetics and pharmacoepidemiology. Pharmacoepidemiol Drug Safe 2001;10:457-461.

Jones JK. The role of data mining technology in the identification of signals of possible adverse drug reactions: value and limitations. Curr Ther Res 2001;62:664-672.

Roswell R, Van Diepen LR, Jones JK, Hicks WE. Adverse drug reactions. Lancet 2001;357:561-562.

Jones JK, Dragone MA, Bush PJ, Kamani SA. An interactive CD-ROM to provide information on leukemia to children and their families. The Patient's Network 2000;5:19-20.

Suarez AP, Staffa JA, Fletcher P, Jones JK. Reason for Discontinuation of newly prescribed antihypertensive medications; methods of a pilot study using computerized patient records. Pharmacoepidemiol Drug Safe 2000;9:405-416.

Isacsson G, Boethius G, Henriksson S, Jones JK, Bergman U. Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J Affect Disord 1999;53:15-22.

Jones JK, Van de Carr SW, Rosa F, Morse L, LeRoy A. Medicaid Drug-event data: an emerging tool for evaluation of drug risk. Acta Medica Scandinavica Supplementum 1998;683:127-132.

Miwa LJ, Jones JK. Chapter 11. Adverse Drug Reactions Attributed to Ibuprofen: Effects Other than Gastrointestinal. In Rainsford KD (ed.) Ibuprofen: A Critical Bibliographic Review. Taylor and Francis, Ltd. 1999:498-538.

Pathiyal A, Hylan TR, Quik R, Jones JK. Antidepressant use and resource utilization in the general practitioner setting in the Netherlands. Pharmacoepidemiol Drug Safe 1998;7:253-260.

Dai WS, Xue S, Yoo K, Jones JK, LaBraico JM. An investigation of the safety of midazolam use in hospital. Pharmacoepidemiol Drug Safe 1997;6:79-87.

Miwa LJ, Jones JK, Pathiyal A, Hatoum H. Value of epidemiologic studies in determining the true incidence of adverse events: the nonsteroidal anti-inflammatory drug story. Arch Intern Med 1997;157:2129-2136.

Shroff AP, Jones JK. Reactions to povidone iodine preparation. JAMA 1997;243:230-231.

Hollister LE, Jones JK, Fisher S. Post-marketing surveillance of drugs. Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines. Raven Press; 1996.

Floor MK, Jones JK, Devlies J. MEDIDOC -- a computerized patient record for primary care. Requirements and benefits of a CPR in the context of disease prevention and health promotion. In: Tamura M, ed. Health Tactics in the 21st Century. International Health Evaluation Association; 1995:351-355.

Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995;311:293-295.

Staffa JA, Jones JK, Gable CB, Verspeelt JP, Amery WK. Risk of Selected Serious Cardiac Events Among New Users of Antihistamines. Clin Ther 1995;17:1062-1077.

Jones JK. Radiocontrast media: regulatory aspects. Investigative Radiology 1994;29 (Suppl 3).

Jones JK. Inpatient databases. In: Strom BL ed. Pharmacoepidemiology. New York, NY: John Wiley & Sons; 1994:257-276.

Jones JK. Determining causation from case reports. In: Strom BL ed. Pharmacoepidemiology. New York, NY: John Wiley & Sons; 1994:365-378.

Gable CB, Jones JK, Lian JF, Rajan M, Kennedy C. Chronic sinusitis: Temporal occurrence and relationship to medical claims for upper respiratory infections and allergic rhinitis. Pharmacoepidemiol Drug Safe 1994;3:337-349.